Showing 7211-7220 of 21432 results for "".
- Arcutis Submits sNDA for Roflumilast for Children 2 to 5 with ADhttps://reachmd.com/news/arcutis-submits-snda-for-roflumilast-for-children-2-to-5-with-ad/2470671/Arcutis Biotherapeutics, Inc. announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for roflumilast (ZORYVE) cream 0.05%, a once-daily, next-generation phosphodiesterase 4 (PDE4) inhibitor, for the topical treatment of mild-t
- Two Processed Foods to Avoid After 40 to Protect Skin Healthhttps://reachmd.com/news/two-processed-foods-to-avoid-after-40-to-protect-skin-health/2470672/For women over 40, maintaining skin elasticity and reducing wrinkles becomes a growing concern. However, certain processed foods can accelerate skin aging, leading to increased wrinkles and inflammation. Experts emphasize that full-fat butter/margarine and white bread are two culprits that may co
- Moving Toward Opioid-Free Surgery: A New Era in Pain Managementhttps://reachmd.com/news/moving-toward-opioid-free-surgery-a-new-era-in-pain-management/2468749/The opioid crisis continues to present significant challenges in the United States, with over 2.5 million adults diagnosed with opioid use disorder in 2022 and opioids implicated in nearly 76% of overdose deaths. As concerns grow over the risks associated with these medications, the
- High Prevalence of Osteoporosis Found Among Lupus Nephritis Patientshttps://reachmd.com/news/high-prevalence-of-osteoporosis-found-among-lupus-nephritis-patients/2468751/A recent study published in BMC Nephrology highlights the significant burden of osteoporosis among patients with lupus nephritis (LN), particularly postmenopausal women. Conducted in China, the study provides valuable insights into the risk factors driving bone mineral
- FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitishttps://reachmd.com/news/fda-approves-nemluvio-moderate-severe-atopic-dermatitis/2470663/Galderma’s Nemluvio® (nemolizumab) has received FDA approval for moderate-to-severe atopic dermatitis in patients aged 12 and older, offering a novel treatment option targeting IL-31. According to a press release from Galderma, the approval follows results from the phase III ARCADIA trial
- Advancements in Digital Eye Models Revolutionize Cataract Surgeryhttps://reachmd.com/news/advancements-digital-eye-models-revolutionize-cataract-surgery/2468769/EU researchers have developed advanced digital models of the eye, dramatically improving the safety and accuracy of cataract surgeries. These models offer personalized surgical plans, benefiting millions across Europe. <
- Exploring DNA Damage in Age-Related Macular Degeneration: A Step Towards New Treatmentshttps://reachmd.com/news/exploring-dna-damage-age-related-macular-degeneration-step-towards-new-treatments/2468768/Recent research has illuminated the significant role that DNA damage plays in age-related macular degeneration (AMD), potentially paving the way for new therapeutic interventions. What's New The article discusses a groundbr
- Study: Cutaneous Lupus Linked with Elevated Cardiovascular Disease Riskhttps://reachmd.com/news/study-cutaneous-lupus-linked-with-elevated-cardiovascular-disease-risk/2468727/Key Takeaways Cutaneous lupus erythematosus (CLE) patients have a significantly increased risk for atherosclerotic cardiovascular disease (ASCVD) comparable to systemic lupus erythematosus (SLE), but higher than psoriasis. Incident ASCVD rates over three years
- Study Explores Genetic Link Between Depression and Period Painhttps://reachmd.com/news/study-explores-genetic-link-between-depression-and-period-pain/2468750/The complex connection between period pain and depression is better understood thanks to a new study published in Briefings in Bioinformatics. Researchers have identified specific genes associated with depression that may increase the likelihood of menstrual pain by 51%. These findings s
- Study Finds Kidney Cancer Risk Even at Low Arsenic Levelshttps://reachmd.com/news/study-finds-kidney-cancer-risk-even-at-low-arsenic-levels/2468753/Emerging research from Texas A&M University suggests that exposure to low levels of arsenic in drinking water may significantly increase the risk of kidney cancer, raising concerns about whether current regulatory standards are sufficient to protect public health. The findings, published in <